-
Bertoletti A, Kennedy PT, 2015: The immune tolerant phase of chronic HBV infection: new perspectives on an old concept[J]. Cell Mol Immunol, 12, 258-263. doi: 10.1038/cmi.2014.79
-
Bility MT, Cheng L, Zhang Z, Luan Y, Li F, Chi L, Zhang L, Tu Z, Gao Y, Fu Y, Niu J, Wang F, Su L, 2014: Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages[J]. PLoS Pathog, 10, e1004032-. doi: 10.1371/journal.ppat.1004032
-
Billerbeck E, Mommersteeg MC, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michailidis E, Dorner M, Krishnan A, Charlton MR, Chiriboga L, Rice CM, de Jong YP, 2016: Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells[J]. J Hepatol, 65, 334-343. doi: 10.1016/j.jhep.2016.04.022
-
Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM, 2010: Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment[J]. J Clin Investig, 120, 924-930. doi: 10.1172/JCI40094
-
Broering R, Lutterbeck M, Trippler M, Kleinehr K, Poggenpohl L, Paul A, Gerken G, Schlaak JF, 2014: Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I: C treatment[J]. J Viral Hepat, 21, 480-490. doi: 10.1111/jvh.12174
-
Chen Z, Cheng Y, Xu Y, Liao J, Zhang X, Hu Y, Zhang Q, Wang J, Zhang Z, Shen F, Yuan Z, 2008: Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients[J]. Clin Immunol, 128, 400-408. doi: 10.1016/j.clim.2008.04.006
-
Chen J, Wu M, Zhang X, Zhang W, Zhang Z, Chen L, He J, Zheng Y, Chen C, Wang F, Hu Y, Zhou X, Wang C, Xu Y, Lu M, Yuan Z, 2013: Hepatitis B virus polymerase impairs interferon-alpha-induced STA T activation through inhibition of importin-alpha5 and protein kinase C-delta[J]. Hepatology, 57, 470-482. doi: 10.1002/hep.26064
-
Cheng X, Xia Y, Serti E, Block PD, Chung M, Chayama K, Rehermann B, Liang TJ, 2017: Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages[J]. Hepatology, 66, 1779-1793. doi: 10.1002/hep.29348
-
Dandri M, Locarnini S, 2012: New insight in the pathobiology of hepatitis B virus infection[J]. Gut, 61, i6-17. doi: 10.1136/gutjnl-2012-302056
-
Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, Lascar RM, Brown D, Gilson RJ, Tedder RJ, Dusheiko GM, Jacobs M, Klenerman P, Maini MK, 2009: Temporal analysis of early immune responses in patients with acute hepatitis B virus infection[J]. Gastroenterology, 137, 1289-1300. doi: 10.1053/j.gastro.2009.06.054
-
Dusseaux M, Masse-Ranson G, Darche S, Ahodantin J, Li Y, Fiquet O, Beaumont E, Moreau P, Riviere L, Neuveut C, Soussan P, Roingeard P, Kremsdorf D, Di Santo JP, Strick-Marchand H, 2017: Viral load affects the immune response to HBV in mice with humanized immune system and liver[J]. Gastroenterology, 153, 1647-1661. doi: 10.1053/j.gastro.2017.08.034
-
Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV, 1996: Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes[J]. Immunity, 4, 25-36. doi: 10.1016/S1074-7613(00)80295-2
-
Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, Broxtermann M, Tedjokusumo R, Esser K, Arzberger S, Kirschning CJ, Langenkamp A, Falk C, Buning H, Rose-John S, Protzer U, 2009: Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection[J]. Hepatology, 50, 1773-1782. doi: 10.1002/hep.23226
-
Huang Z, Ge J, Pang J, Liu H, Chen J, Liao B, Huang X, Zuo D, Sun J, Lu M, Zhang X, Hou J, 2015: Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy[J]. Antivir Res, 118, 10-19. doi: 10.1016/j.antiviral.2015.03.004
-
Isogawa M, Robek MD, Furuichi Y, Chisari FV, 2005: Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J]. J Virol, 79, 7269-7272. doi: 10.1128/JVI.79.11.7269-7272.2005
-
Knolle PA, Thimme R, 2014: Hepatic immune regulation and its involvement in viral hepatitis infection[J]. Gastroenterology, 146, 1193-1207. doi: 10.1053/j.gastro.2013.12.036
-
Li M, Sun R, Xu L, Yin W, Chen Y, Zheng X, Lian Z, Wei H, Tian Z, 2015: Kupffer cells support hepatitis B virus-mediated CD8 + T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice[J]. J Immunol, 195, 3100-3109. doi: 10.4049/jimmunol.1500839
-
Liu S, Peng N, Xie J, Hao Q, Zhang M, Zhang Y, Xia Z, Xu G, Zhao F, Wang Q, Han T, Zhu Y, 2015: Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways[J]. J Hepatol, 62, 1015-1023. doi: 10.1016/j.jhep.2014.11.035
-
Liu J, Yu Q, Wu W, Huang X, Broering R, Werner M, Roggendorf M, Yang D, Lu M, 2018: TLR2 stimulation strengthens intrahepatic myeloid-derived cell-mediated T cell tolerance through inducing Kupffer cell expansion and IL-10 production[J]. J Immunol, 200, 2341-2351. doi: 10.4049/jimmunol.1700540
-
Lutgehetmann M, Mancke LV, Volz T, Helbig M, Allweiss L, Bornscheuer T, Pollok JM, Lohse AW, Petersen J, Urban S, Dandri M, 2012: Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation[J]. Hepatology, 55, 685-694. doi: 10.1002/hep.24758
-
Song H, Tan G, Yang Y, Cui A, Li H, Li T, Wu Z, Yang M, Lv G, Chi X, Niu J, Zhu K, Crispe IN, Su L, Tu Z, 2019: Hepatitis B virus-induced imbalance of inflammatory and antiviral signaling by differential phosphorylation of STAT1 in human monocytes[J]. J Immunol, 202, 2266-2275. doi: 10.4049/jimmunol.1800848
-
Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S, 2007: Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein[J]. Hepatology, 45, 102-110. doi: 10.1002/hep.21482
-
Wieland SF, Chisari FV, 2005: Stealth and cunning: hepatitis B and hepatitis C viruses[J]. J Virol, 79, 9369-9380. doi: 10.1128/JVI.79.15.9369-9380.2005
-
Wieland S, Thimme R, Purcell RH, Chisari FV, 2004: Genomic analysis of the host response to hepatitis B virus infection[J]. Proc Natl Acad Sci USA, 101, 6669-6674.
-
Wu J, Huang S, Zhao X, Chen M, Lin Y, Xia Y, Sun C, Yang X, Wang J, Guo Y, Song J, Zhang E, Wang B, Zheng X, Schlaak JF, Lu M, Yang D, 2014: Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model[J]. J Virol, 88, 10421-10431. doi: 10.1128/JVI.00996-14
-
Xu C, Lu Y, Zheng X, Feng X, Yang X, Timm J, Wu J, Wang B, Lu M, Yang D, Liu J, 2017: TLR2 expression in peripheral CD4 + T cells promotes Th17 response and is associated with disease aggravation of hepatitis B virus-related acute-on-chronic liver failure[J]. Front Immunol, 8, 1609-.
-
Zhang X, Ma Z, Liu H, Liu J, Meng Z, Broering R, Yang D, Schlaak JF, Roggendorf M, Lu M, 2012: Role of Toll-like receptor 2 in the immune response against hepadnaviral infection[J]. J Hepatol, 57, 522-528. doi: 10.1016/j.jhep.2012.05.004
-
Zhang Z, Trippler M, Real CI, Werner M, Luo X, Schefczyk S, Kemper T, Anastasiou OE, Ladiges Y, Treckmann J, Paul A, Baba HA, Allweiss L, Dandri M, Gerken G, Wedemeyer H, Schlaak JF, Lu M, Broering R, 2020: Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes[J]. Hepatology, , -. doi: 10.1002/hep.31112
-
Zhou Y, Li S, Tang Z, Xu C, Huang S, Wu J, Dittmer U, Dickow J, Sutter K, Lu M, Yang D, Song J, 2017: Different antiviral effects of IFNalpha and IFNbeta in an HBV mouse model[J]. Immunobiology, 222, 562-570.